Drug profile · INN
dacarbazine
DACARBAZINE
dacarbazine (DACARBAZINE) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — dacarbazine
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 6
- Programs
- 9
- Data quality
- 0.84
Quick answer
dacarbazine (DACARBAZINE) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12258354
AhR modulators
granted -
US 11584755
Dihydrothieno[3,2-b]pyridine compounds
granted -
US 11548867
Amido compounds as AhR modulators
granted -
US 11530220
Substituted imidazo[1,5-a]pyrazines and [1,2,4]triazolo[4,3-a]pyrazines for the modulation of AhR
granted -
US 11407764
AhR modulators
granted -
US 10815250
AhR modulators
granted
Frequently asked questions
What is dacarbazine?
dacarbazine (DACARBAZINE) is a dna inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for dacarbazine?
DACARBAZINE is a marketed brand name for dacarbazine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dacarbazine?
dacarbazine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.